{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:48:21Z","timestamp":1784342901712,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202301AT070241"],"award-info":[{"award-number":["202301AT070241"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Grants in Ophthalmology, a National Key Clinical Specialty at the Affiliated Hospital of Yunnan University","award":["ZKF2024055"],"award-info":[{"award-number":["ZKF2024055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20065-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:19:40Z","timestamp":1760527180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of retinal angiogenesis induced by HIF-1\u03b1 and HIF-2\u03b1 under hyperoxic conditions"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaoxiao","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"20065_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"WV Good","year":"2005","unstructured":"Good, W. V. et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116, 15\u201323 (2005).","journal-title":"Pediatrics"},{"key":"20065_CR2","doi-asserted-by":"crossref","unstructured":"Richards, M. P. M. & Retrolental fibroplasia: A modern parable. By W. A. Silverman. (Grune \\& Stratton, New York 1980) Price \u00a313.20 (US \\$23.50).  J. Biosoc. Sci. 13, 501\u2013503 (1981).","DOI":"10.1017\/S0021932000013754"},{"key":"20065_CR3","doi-asserted-by":"crossref","unstructured":"Pierce, E. A., Foley, E. D. & Smith, L. E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol. (Chicago, Ill.  1960)  114, 1219\u20131228 (1996).","DOI":"10.1001\/archopht.1996.01100140419009"},{"key":"20065_CR4","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101\u2013111 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"20065_CR5","doi-asserted-by":"publisher","first-page":"110170","DOI":"10.1016\/j.exer.2024.110170","volume":"250","author":"X Feng","year":"2025","unstructured":"Feng, X. et al. Tracking astrocyte polarization in the retina in retinopathy of prematurity. Exp. Eye Res. 250, 110170 (2025).","journal-title":"Exp. Eye Res."},{"key":"20065_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4103\/1673-5374.133169","volume":"9","author":"J Deng","year":"2025","unstructured":"Deng, J. et al. The development of blood-retinal barrier during the interaction of Ast Rocytes with vascular wall cells. Neural Regen Res. 9, 1047 (2025).","journal-title":"Neural Regen Res."},{"key":"20065_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0165-3806(87)90162-3","volume":"33","author":"JB Grinspan","year":"1987","unstructured":"Grinspan, J. B. et al. Rat brain microvessel extracellular matrix modulates the phenotype of cultured rat type 1 astroglia. Dev. Brain Res. 33, 291\u2013295 (1987).","journal-title":"Dev. Brain Res."},{"key":"20065_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-024-01269-7","volume":"14","author":"X Sheng","year":"2024","unstructured":"Sheng, X. et al. Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components. Cell. Biosci. 14, 85 (2024).","journal-title":"Cell. Biosci."},{"key":"20065_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3928\/01913913-20200824-02","volume":"57","author":"CW Seery","year":"2020","unstructured":"Seery, C. W. et al. Update on the use of Anti-VEGF drugs in the treatment of retinopathy of prematurity. J. Pediatr. Ophthalmol. Strabismus. 57, 351\u2013362 (2020).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"20065_CR10","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1172\/JCI65157","volume":"122","author":"T Kurihara","year":"2012","unstructured":"Kurihara, T., Westenskow, P. D., Bravo, S., Aguilar, E. & Friedlander, M. Targeted deletion of Vegfa in adult mice induces vision loss. J. Clin. Invest. 122, 4213\u20134217 (2012).","journal-title":"J. Clin. Invest."},{"key":"20065_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ophtha.2013.11.029","volume":"121 5","author":"SJ Bakri","year":"2014","unstructured":"Bakri, S. J. et al. Intraocular pressure in eyes receiving monthly Ranibizumab in 2 pivotal age-related macular degeneration clinical trials. Ophthalmology 121 5, 1102\u20131108 (2014).","journal-title":"Ophthalmology"},{"key":"20065_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","volume":"121","author":"JE Grunwald","year":"2014","unstructured":"Grunwald, J. E. et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121, 150\u2013161 (2014).","journal-title":"Ophthalmology"},{"key":"20065_CR13","doi-asserted-by":"crossref","unstructured":"Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007 cm8  (2007).","DOI":"10.1126\/stke.4072007cm8"},{"key":"20065_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3, 721\u2013732 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"20065_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith, B., Johnson, R. S. & Simon, M. C. HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer. 12, 9\u201322 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"20065_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.med.54.101601.152418","volume":"54","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54, 17\u201328 (2003).","journal-title":"Annu. Rev. Med."},{"key":"20065_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/scdb.2001.0287","volume":"13","author":"PH Maxwell","year":"2002","unstructured":"Maxwell, P. H. & Ratcliffe, P. J. Oxygen sensors and angiogenesis. Semin Cell. Dev. Biol. 13, 29\u201337 (2002).","journal-title":"Semin Cell. Dev. Biol."},{"key":"20065_CR18","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604\u20134613 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"20065_CR19","doi-asserted-by":"publisher","first-page":"32405","DOI":"10.1074\/jbc.C200328200","volume":"277","author":"Y Makino","year":"2002","unstructured":"Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. & Poellinger, L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J. Biol. Chem. 277, 32405\u201332408 (2002).","journal-title":"J. Biol. Chem."},{"key":"20065_CR20","doi-asserted-by":"publisher","first-page":"C260","DOI":"10.1152\/ajpcell.00315.2015","volume":"310","author":"C Duan","year":"2016","unstructured":"Duan, C. Hypoxia-inducible factor 3 biology: complexities and emerging themes. Am. J. Physiol. Cell. Physiol. 310, C260\u2013C269 (2016).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"20065_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1096\/fj.05-3788com","volume":"19","author":"MA Maynard","year":"2005","unstructured":"Maynard, M. A. et al. Human HIF-3\u03b14 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J. 19, 1396\u20131406 (2005).","journal-title":"FASEB J."},{"key":"20065_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yexcr.2017.03.030","volume":"356","author":"DJ Peet","year":"2017","unstructured":"Peet, D. J., Kittipassorn, T., Wood, J. P., Chidlow, G. & Casson, R. J. HIF signalling: the eyes have it. Exp. Cell. Res. 356, 136\u2013140 (2017).","journal-title":"Exp. Cell. Res."},{"key":"20065_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","volume":"62","author":"ME Hartnett","year":"2017","unstructured":"Hartnett, M. E. Advances in Understanding and management of retinopathy of prematurity. Surv. Ophthalmol. 62, 257\u2013276 (2017).","journal-title":"Surv. Ophthalmol."},{"key":"20065_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024\u20131028 (1995).","journal-title":"Nat. Med."},{"key":"20065_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/glia.22956","volume":"64","author":"A Giocanti-Auregan","year":"2016","unstructured":"Giocanti-Auregan, A. et al. Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice. Glia 64, 716\u2013729 (2016).","journal-title":"Glia"},{"key":"20065_CR26","first-page":"3500","volume":"43","author":"MI Dorrell","year":"2002","unstructured":"Dorrell, M. I., Aguilar, E. & Friedlander, M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest. Ophthalmol. Vis. Sci. 43, 3500\u20133510 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"20065_CR27","first-page":"139","volume":"176","author":"A Bulent Ozpolata","year":"2016","unstructured":"Bulent Ozpolata, A. et al. Gay, and L. Z. Multiple roles for Pax2 in the embryonic mouse eye. Dev. Biol. 176, 139\u2013148 (2016).","journal-title":"Dev. Biol."},{"key":"20065_CR28","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1167\/iovs.03-1169","volume":"45","author":"T Chan-Ling","year":"2004","unstructured":"Chan-Ling, T. et al. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest. Ophthalmol. Vis. Sci. 45, 2020\u20132032 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"20065_CR29","doi-asserted-by":"publisher","first-page":"E3030","DOI":"10.1073\/pnas.1423765112","volume":"112","author":"S Babapoor-Farrokhran","year":"2015","unstructured":"Babapoor-Farrokhran, S. et al. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. Proc. Natl. Acad. Sci. U S A. 112, E3030\u2013E3039 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"20065_CR30","first-page":"290","volume":"37","author":"J Stone","year":"1996","unstructured":"Stone, J. et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Investig Ophthalmol. Vis. Sci. 37, 290\u2013299 (1996).","journal-title":"Investig Ophthalmol. Vis. Sci."},{"key":"20065_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.tcb.2019.10.001","volume":"29","author":"L Yap","year":"2019","unstructured":"Yap, L., Tay, H. G., Nguyen, M. T. X., Tjin, M. S. & Tryggvason, K. Laminins in cellular differentiation. Trends Cell. Biol. 29, 987\u20131000 (2019).","journal-title":"Trends Cell. Biol."},{"key":"20065_CR32","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/ATVBAHA.123.319119","volume":"43","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Extracellular matrix stiffness regulates microvascular stability by controlling endothelial paracrine signaling to determine pericyte fate. Arterioscler. Thromb. Vasc Biol. 43, 1887\u20131899 (2023).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"20065_CR33","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565\u20131573 (2009).","journal-title":"Nat. Protoc."},{"key":"20065_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fphar.2020.00873","volume":"11","author":"M V\u00e4h\u00e4tupa","year":"2020","unstructured":"V\u00e4h\u00e4tupa, M., J\u00e4rvinen, T. A. H. & Uusitalo-J\u00e4rvinen, H. Exploration of Oxygen-Induced retinopathy model to discover new therapeutic drug targets in retinopathies. Front. Pharmacol. 11, 873 (2020).","journal-title":"Front. Pharmacol."},{"key":"20065_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.2.3","volume":"61","author":"M Sun","year":"2020","unstructured":"Sun, M. et al. Epithelial membrane protein 2 (EMP2) promotes VEGF-Induced pathological neovascularization in murine Oxygen-Induced retinopathy. Invest. Ophthalmol. Vis. Sci. 61, 3 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"20065_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40659-024-00515-z","volume":"57","author":"Y Guo","year":"2024","unstructured":"Guo, Y. et al. Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice. Biol. Res. 57, 43 (2024).","journal-title":"Biol. Res."},{"key":"20065_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mcn.2013.06.001","volume":"56","author":"F Bucher","year":"2013","unstructured":"Bucher, F., Stahl, A., Agostini, H. T. & Martin, G. Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy. Mol. Cell. Neurosci. 56, 225\u2013233 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"20065_CR38","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1080\/15384101.2022.2087277","volume":"21","author":"K Zhao","year":"2022","unstructured":"Zhao, K. et al. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p\/HIF-1\u03b1\/VEGF pathway. Cell. Cycle. 21, 2091\u20132108 (2022).","journal-title":"Cell. Cycle"},{"key":"20065_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/mol.109.061366","volume":"77","author":"M DeNiro","year":"2010","unstructured":"DeNiro, M., Al-Halafi, A., Al-Mohanna, F. H., Alsmadi, O. & Al-Mohanna, F. A. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol. Pharmacol. 77, 348\u2013367 (2010).","journal-title":"Mol. Pharmacol."},{"key":"20065_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ydbio.2020.12.020","volume":"472","author":"B Bosze","year":"2021","unstructured":"Bosze, B. et al. Multiple roles for Pax2 in the embryonic mouse eye. Dev. Biol. 472, 18\u201329 (2021).","journal-title":"Dev. Biol."},{"key":"20065_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/glia.20733","volume":"57","author":"T Chan-Ling","year":"2009","unstructured":"Chan-Ling, T., Chu, Y., Baxter, L., Weible Ii, M. & Hughes, S. In vivo characterization of astrocyte precursor cells (APCs) and astrocytes in developing rat retinae: differentiation, proliferation, and apoptosis. Glia 57, 39\u201353 (2009).","journal-title":"Glia"},{"key":"20065_CR42","unstructured":"Nystr\u00f6m, A. Laminins in Blood Vessel Development and Disease -Functional Aspects in Angiogenesis, Atherosclerosis, and Muscular Dystrophy (Department of Experimental Medical Science Lund University, 2006)."},{"key":"20065_CR43","doi-asserted-by":"publisher","first-page":"17608","DOI":"10.1038\/s41598-017-17962-2","volume":"7","author":"LJ Duan","year":"2017","unstructured":"Duan, L. J., Pan, S. J., Sato, T. N. & Fong, G. H. Retinal angiogenesis regulates astrocytic differentiation in neonatal mouse retinas by oxygen dependent mechanisms. Sci. Rep. 7, 17608 (2017).","journal-title":"Sci. Rep."},{"key":"20065_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vph.2016.07.007","volume":"90","author":"SW Park","year":"2017","unstructured":"Park, S. W. et al. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Vascul Pharmacol. 90, 19\u201326 (2017).","journal-title":"Vascul Pharmacol."},{"key":"20065_CR45","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. HIF-1\u03b1 and HIF-2\u03b1 redundantly promote retinal neovascularization in patients with ischemic retinal disease. J. Clin. Invest. 131, (2021).","DOI":"10.1172\/JCI139202"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20065-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:19:43Z","timestamp":1760527183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20065-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20065"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20065-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Kunming Medical University (Kmmu20231525) and was conducted according to the ARRIVE guidelines. We confirm that all experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"36049"}}